Skip to main content
Premium Trial:

Request an Annual Quote

LSU Health Sciences Center Wins $2.4M to Lead SARS-CoV-2 Variant Sequencing Program

NEW YORK — The Louisiana State University Health Sciences Center said last week that it has received $2.4 million from the National Institutes of Health and the Louisiana Department of Health, or LDH, to oversee a project sequencing SARS-CoV-2 variants.

LSU Health said that the initiative will sequence SARS-CoV-2 samples from breakthrough cases, reinfected individuals, the unvaccinated, and vulnerable individuals such as cancer patients, transplant recipients, and those receiving immunosuppressant drugs. Samples will also be taken from underserved and minority patients, with Xavier University performing community engagement and health literacy work for those populations.

The LDH and the LSU Health New Orleans School of Medicine will handle patient sampling, and sequencing will be performed by LSU Health New Orleans. Analytics and data interpretation will be conducted in collaboration with Louisiana-based informatics firm BIE.

The funding comes from a contract with the LDH and from a supplement to the Louisiana Clinical & Translational Science Center grant from the National Institute of General Medical Sciences.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.